UK markets closed

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
285.11+3.11 (+1.06%)
As of 11:17AM EDT. Market open.
Show:
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,474,000
16,474,000
14,505,000
8,417,000
10,111,000
Cost of revenue
226,000
226,000
0
0
-
Gross profit
16,248,000
16,248,000
14,505,000
8,417,000
-
Operating expenses
Research development
7,630,000
7,630,000
5,562,000
4,181,000
3,137,000
Selling general and administrative
3,297,000
3,297,000
2,676,000
1,283,000
661,000
Total operating expenses
10,927,000
10,927,000
8,238,000
5,464,000
3,798,000
Operating income or loss
5,321,000
5,321,000
6,267,000
2,953,000
6,313,000
Interest expense
27,000
27,000
21,000
13,000
10,000
Total other income/expenses net
-596,000
-596,000
375,000
781,000
-583,000
Income before tax
5,637,000
5,637,000
6,945,000
3,918,000
5,904,000
Income tax expense
1,285,000
1,285,000
1,493,000
961,000
1,146,000
Income from continuing operations
4,352,000
4,352,000
5,452,000
2,957,000
4,758,000
Net income
4,352,000
4,352,000
5,452,000
2,957,000
4,758,000
Net income available to common shareholders
4,352,000
4,352,000
5,452,000
2,957,000
4,758,000
Basic EPS
65.81
-
83.38
45.22
73.00
Diluted EPS
65.17
-
82.59
44.77
72.21
Basic average shares
65,301
-
65,387
65,396
65,179
Diluted average shares
65,923
-
66,010
66,046
65,886